ALGS NASDAQ
Aligos Therapeutics, Inc.
1W: +0.5%
1M: -10.8%
3M: -5.3%
YTD: -39.3%
1Y: -46.2%
3Y: -68.8%
5Y: -98.6%
$5.54
+0.04 (+0.73%)
Weekly Expected Move ±6.3%
$5
$5
$6
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$32M
Revenue
+893.0% YoY
$-76M
Net Income
-2.4% YoY
$-95M
Free Cash Flow
-25.8% YoY
100.0%
Gross Margin
-6.8%
Op. Margin
-5.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-113.6%
ROA-75.6%
ROIC-1246.4%
Valuation
P/E-0.8
P/B1.8
EV/EBITDA-0.5
Leverage
Debt/Equity0.11
Current Ratio2.19
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-15.56
Beneish M23.85